Glenmark Pharma and AbbVie (ABBV) announces exclusive global licensing agreement for ISB 2001, Glenmark Pharma will receive an upfront USD 700mln payment and is eligible to receive up to USD 1.225bln.
10 Jul 2025 - 12:27- ForexExclusive- Source: Newswires
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts